For instance, Pan et al. (2010) [25], in a landmark study, investigated the effects of chronic treatment by BFT in amyloid precursor protein/presenilin (APP/PS1) double transgenic mice, a classical model of Alzheimer’s disease. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.